Your census is full, your clinical team is delivering good care, and your bank balance still does not add up. If you run an addiction treatment center, that gap almost always lives in billing: roughly 60 percent of a typical facility's revenue arrives through insurance reimbursement, which means a denied week of residential care, a toxicology audit, or a contract rate you never modeled can erase a month of margin overnight. This guide walks through how treatment-center billing actually works — in-network contracts versus out-of-network reimbursement, prior authorization, balance-billing rules, drug-testing billing, patient collections, and the accreditation that unlocks payer contracts — so you can build a revenue cycle that survives scrutiny.
Start With Your True Cost of Care
Before you negotiate a single payer contract, you need one number most operators cannot state with confidence: what it costs you to deliver one day of care.
Build it bottom-up. Add facility costs (rent, utilities, maintenance), staffing costs (clinical, medical, and support payroll with benefits), administrative costs (billing, admissions, compliance, EHR), and marketing and outreach costs — then divide by occupied bed-days at your realistic occupancy, not full census. A residential bed that costs $500 a day at 100 percent occupancy costs about $667 a day at 75 percent occupancy, because most of your costs do not leave when a bed sits empty. Run the math at full census and at your trailing twelve-month average occupancy, and use the higher figure when you evaluate contract rates.
That cost figure does three jobs. It sets the floor under your billed rates, it tells you which payer contracts are worth signing, and it lets you negotiate from data instead of hope. When you do sign, build automatic annual inflation adjustments of 2 to 5 percent — "risers" — into the contract language, because a flat rate is a pay cut every year your labor costs rise. And start the contracting conversation early: payers plan networks months ahead, so operators who open talks in the fall for the following year consistently land better terms than those who rush credentialing weeks before they need referrals.
Billed rates need reasonable margins
Your chargemaster — the list price of every service you bill — should reflect your calculated cost plus a margin consistent with other areas of health care, not a number copied from a competitor down the road. Inflated list prices do not just look bad in an audit; they distort every downstream decision, from contract modeling to patient estimates.
Track, claim by claim, what each payer actually allows and what you actually collect after appeals. That collection rate, net of your billing cost, is your real margin — and it is the only number that tells you whether a contract deserves renewal. As your collection rate climbs, expect billing costs to climb with it: appeals, clinical reviews, and authorization staff are expensive, whether in-house or outsourced. Budget for that cost explicitly instead of discovering it in the P&L.
In-Network Contracts vs. Out-of-Network Reimbursement
This is the central strategic choice in treatment-center revenue, and most of your billing headaches flow from it.
In-network means you hold a signed contract with the payer: pre-negotiated allowed amounts, the patient's lower in-network deductible and copays, and a steadier referral stream — in exchange for lower per-day rates and stricter authorization rules. Collections are simpler because the contract defines exactly what you may bill and what the patient owes, and many contracts (HMO contracts nearly always) prohibit balance billing members entirely.
Out-of-network means no contract: you bill your full charges, the payer reimburses at whatever it deems usual, customary, and reasonable (UCR) — often far less — and the patient faces a separate, higher out-of-network deductible plus coinsurance, with any unpaid remainder potentially balance-billed to them. Historically, out-of-network billing served as a margin buffer when contracted rates lagged behind real costs. That buffer is shrinking: parity enforcement has pushed payers to scrutinize behavioral-health reimbursement more closely, and 2026 has brought tighter authorization and lower out-of-network allowances across the industry.
Neither path is free. Going in-network trades rate for volume and predictability; staying out-of-network trades simplicity for collection risk and regulatory exposure. What you cannot do is drift: billing out-of-network by default because credentialing felt like too much paperwork is how facilities end up with six-figure aging buckets they will never collect.
Know your UCR rates — and appeal with data
Whether in-network or out, you need to know the usual, customary, and reasonable rates for every service you provide in your market, and you need a written justification for any billed amount that departs significantly from them. UCR data is also your appeals weapon: claims paid below UCR can be appealed, and operators who appeal systematically — with cost and market data attached — win a meaningful share of those appeals. The facilities that never appeal are not saving labor; they are donating the difference to the payer.
Prior Authorization and Concurrent Review
Almost every residential stay and intensive outpatient episode requires the payer's permission before admission and at intervals during care. Understanding that cadence is non-negotiable.
- Prior authorization happens before admission: your team submits clinical documentation demonstrating medical necessity, and the payer approves an initial block of days or sessions.
- Concurrent review happens during care: typically a few days before the current authorization expires, you submit updated clinicals — symptoms, functional impairment, risk factors, response to treatment — to justify continued stay.
- Step-down authorization applies when the patient moves to a lower level of care, such as residential to partial hospitalization to intensive outpatient, each with its own medical-necessity bar.
Payers measure medical necessity against clinical criteria, most commonly the ASAM Criteria with its six-dimensional assessment (intoxication risk, biomedical conditions, emotional and behavioral conditions, treatment acceptance, relapse potential, and recovery environment). Your documentation must speak that language: thorough notes on severity, impairment, and progress, tied explicitly to the level of care you are billing. Thin documentation is the single most common reason legitimate days get denied.
Two practical notes. First, several states limit or prohibit prior authorization for the first days of substance-use treatment, so know your state's rules — they may buy your admissions team a crucial window. Second, authorization denials are appealable, and parity law is your backstop: the Mental Health Parity and Addiction Equity Act bars plans from applying financial requirements or treatment limitations to substance-use benefits that are more restrictive than those applied to medical and surgical benefits. Federal agencies confirmed in 2025 that they would not enforce the newer portions of the 2024 parity rule, but the statute itself and the earlier rules remain in force, and the Department of Labor restated in September 2026 that parity compliance is an enforcement priority. If a payer's authorization practices for your residential beds look nothing like its practices for comparable medical stays, that is worth documenting — and appealing.
Balance Billing: What You May and May Not Bill the Patient
Balance billing is the amount left after insurance pays and after the patient's defined cost-sharing (deductibles, copays, coinsurance) — and it is the area where a missing policy becomes a legal problem fastest.
NAATP's billing standards call for a written balance-billing policy that complies with state law, network contracts, and plan documents, applied uniformly to all patients. The essentials:
- Honor your contracts. In-network agreements define exactly what the patient owes; billing beyond that is a contract violation, and HMO contracts generally ban balance billing outright.
- Know the No Surprises Act. Since 2022, federal law has banned surprise balance bills for most emergency services, for out-of-network ancillary care delivered at in-network facilities, and for air ambulances — with patient cost-sharing capped at in-network levels. Scheduled residential treatment at an out-of-network facility is a different posture: with proper notice and signed patient consent, balance-billing protections can be waived for those non-emergency services. The notice-and-consent paperwork is exacting, so treat it as a compliance workflow, not a clipboard form.
- Give uninsured and self-pay patients a good-faith estimate. The same law requires most providers to furnish a written cost estimate before care when the patient is uninsured or paying out of pocket. Build the estimate into admissions so it happens every time, not when someone remembers.
- Communicate in plain language. Every patient should understand, before admission, what their plan covers, what they will owe, and what happens if authorization runs out mid-stay. Clear, consistent financial counseling prevents most of the disputes that end in complaints to regulators.
State surprise-billing laws layer on top of the federal floor with their own disclosure, notification, and signature requirements. Your written policy must reflect your state's version, not a template downloaded from another jurisdiction.
Toxicology: The Line Item Auditors Read First
Drug testing is clinically essential in addiction treatment — and it is the most abused billing category in the industry's history, which is why payers audit it first.
Testing comes in two tiers. Presumptive screens (cup or dip-card immunoassays, CPT 80305–80307) answer "is something present?" cheaply. Definitive tests (mass spectrometry) identify exactly what and how much, at far higher cost. Payers expect presumptive testing first, with definitive testing reserved for confirming unexpected results or quantifying specific substances — not ordered as a standing panel on every patient every week.
Frequency must match medical necessity and be documented in the chart. Medicare's coverage rules, which commercial payers widely mirror, allow roughly up to three presumptive tests per week for patients in early treatment with under 30 days of abstinence, tapering as sobriety lengthens — and commercial plans commonly cap definitive testing at around a dozen tests per year. Standing orders for daily definitive panels will be denied, and routine over-testing invites recoupment demands reaching back over paid claims.
NAATP's standard is direct: maintain a written toxicology policy, individualize test selection to each patient's clinical needs — disease severity, prior results, length of sobriety, stated history, relapse risk — and bill amounts reasonably related to the actual cost of providing the service. If your lab bill and your billed charges for the same test live on different planets, fix that before a payer's special-investigations unit notices.
Deductibles and Copays: Collect What the Policy Says
Patient financial responsibility — deductibles, copays, coinsurance — must be collected under a written, consistently applied policy. That sentence sounds obvious until you learn what the industry norm used to be: routinely waiving the patient's share as a marketing inducement ("your insurance covers everything, you pay nothing").
Routine waiver is prohibited. It misrepresents your true charges to the payer, it can violate your network contracts and insurance-fraud statutes, and it trains patients to choose facilities on the size of the inducement rather than the quality of care. The only acceptable exceptions are demonstrable financial hardship under written, objective criteria aligned with the payer's policy — documented case by case, never as standard practice.
The compliant alternative is unglamorous but effective: verify benefits before admission, collect the estimated patient share up front or on a written payment plan, and follow up systematically. Patient collections have become a larger share of facility revenue as deductibles have risen across commercial plans, so this function deserves staff, scripts, and software — not whoever has a free afternoon.
The Accreditation That Unlocks Payer Contracts
License, accreditation, and network status are three different things, and confusing them stalls contracting for months.
- Licensure comes from your state and is permission to operate. It is mandatory and says nothing about quality beyond minimum standards.
- Accreditation comes from an independent body — in behavioral health, principally the Joint Commission or CARF — after an on-site survey of clinical programming, staffing credentials, patient safety, documentation, and governance, renewed on a cycle of up to three years. It is technically voluntary.
- Network status comes from each payer individually, through credentialing and contracting.
Here is why the "voluntary" label misleads: many states require accreditation for licensure at certain levels of care, and many payers require Joint Commission or CARF accreditation before they will credential a facility at all. An unaccredited facility is not merely less impressive — in many markets it is simply ineligible for in-network contracts, which pushes it into the shrinking out-of-network posture described above. Accreditation surveys also force the documentation discipline that wins authorization appeals, so the investment pays back in the revenue cycle, not just the lobby plaque.
Verify any facility's status through the accreditor's public search tool, and confirm the accreditation covers the specific program and site — not a sister location. If you are opening a new program, sequence accreditation before payer contracting in your project plan, and budget six to twelve months for survey readiness; the operators who treat it as a checkbox discover during the survey that it is an operating system.
Common Billing Mistakes That Cost Treatment Centers Money
Most revenue leakage traces to a short list of avoidable errors:
- Billing without knowing cost. If you cannot state your cost per bed-day at realistic occupancy, you cannot evaluate a contract rate. Calculate it first.
- Letting authorizations lapse. A day of care delivered without authorization is usually a day you cannot bill. Calendar concurrent-review deadlines and submit clinicals days early.
- Copy-paste documentation. Authorization reviewers and auditors both flag cloned notes. Every day's documentation should reflect that day's patient.
- Standing-order toxicology. Blanket definitive panels invite denials and recoupments. Individualize testing and follow your written policy.
- Waiving patient responsibility as policy. Collect deductibles and copays, offer hardship exceptions only under written criteria, and document each one.
- Never appealing. Denials and below-UCR payments are opening offers, not verdicts. Appeal with cost data and clinical evidence, and track win rates by payer.
Keep Your Cost Data Audit-Ready From Day One
Every recommendation in this guide — cost-based rate setting, UCR appeals, toxicology policies, hardship exceptions — depends on books that can prove what you spent and what you collected. When your cost per bed-day, your collection rate by payer, and your patient-responsibility aging live in one transparent ledger instead of three spreadsheets and a billing vendor's portal, contract negotiations, audits, and accreditation surveys all get easier. If you want to see how that works in practice, the documentation walks through double-entry tracking you can adapt to per-program cost accounting. Beancount.io provides plain-text accounting that gives you complete transparency and control over your financial data — no black boxes, no vendor lock-in. Get started for free and see why developers and finance professionals are switching to plain-text accounting.
